Literature DB >> 29756327

Use of radioiodine-131 scan to measure influence of surgical discipline, practice, and volume on residual thyroid tissue after total thyroidectomy for differentiated thyroid carcinoma.

Jin Soo A Song1, Nico Moolman1, Steven Burrell2, Murali Rajaraman3, Martin Joseph Bullock4, Jonathan Trites1, S Mark Taylor1, Matthew H Rigby1, Robert D Hart1.   

Abstract

BACKGROUND: Our study's purpose is to determine the influence of surgical discipline, surgeon site, and volume on remnant thyroid tissue visualized on radioactive iodine-131 (I-131) scans after total thyroidectomy and I-131 ablation in patients with well-differentiated thyroid carcinomas.
METHODS: We retrospectively reviewed all cases of patients who received I-131 therapeutic ablation and postablation radioactive I-131 scans at our center after thyroidectomy to calculate the fraction of administered dose multiplied by 1000 (UDR1000).
RESULTS: The remnant thyroid tissue (ie, the UDR1000), between academic and community surgeons was 0.471 (±0.705) and 1.190 (±2.487), respectively (P = .001). The UDR1000 between otolaryngology-head and neck surgery and general surgery was 0.654 (±1.575) and 1.043 (±1.625), respectively (P = .159). The UDR1000 partitioned by patient frequencies of <10, 10 to 19, and ≥20 patients yielded 1.255 (±2.554), 0.926 (±2.084), and 0.467 (±0.721), respectively (P = .003).
CONCLUSION: Our study found statistically significant differences in residual thyroid tissue visualized on radioactive I-131 scans based on surgeon parameters.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  differentiated thyroid carcinoma; iodine-131; papillary thyroid carcinoma; radioactive iodine; thyroidectomy

Mesh:

Substances:

Year:  2018        PMID: 29756327     DOI: 10.1002/hed.25204

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  1 in total

1.  The Value of Pre-Ablative I-131 Scan for Clinical Management in Patients With Differentiated Thyroid Carcinoma.

Authors:  Trynke van der Boom; Wouter T Zandee; Claire C J Dekkers; Anouk N A van der Horst-Schrivers; Liesbeth Jansen; Schelto Kruijff; Adrienne H Brouwers; Thera P Links
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-28       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.